Abhishek M P, Mouli Sileveru Chandra, Shariff Mudassar Ahmed, Sravani Maryada, Malik Kirti, Dadwal Himani, Anand Rahul
Department of ENT, Chamarajanagara Institute of Medical Sciences (CIMS), Chamarajanagara, Karnataka, India.
Department of Otorhinolaryngology, Santhiram Medical College and General Hospital, Nandyal, Andhra Pradesh, India.
J Pharm Bioallied Sci. 2024 Jul;16(Suppl 3):S2601-S2604. doi: 10.4103/jpbs.jpbs_408_24. Epub 2024 Jul 1.
Current research compared traditional FESS, balloon sinuplasty, and powered instruments for CRS efficiency.
A prospective comparison analysis of 150 CRS patients who received FESS. The surgical method divided the patients into three groups: Group A (conventional FESS, = 50), Group B (balloon sinuplasty, = 50), and Group C (powered instrumentation, = 50). Primary outcome measures included symptom alleviation, measured preoperatively and six months postoperatively using the "22-item Sino-Nasal Outcome Test (SNOT-22)". Preoperative and six-month postoperative "Short Form 36 (SF-36)" Health Surveys assessed postoperative complications and the quality of life.
Balloon sinuplasty relieved symptoms better than FESS and powered instrumentation. Mean SNOT-22 scores reduced by 62.1% in the balloon sinuplasty group, much higher than the standard FESS and powered instrumentation groups (49.1% and 45.8%, respectively) ( < 0.001). Balloon sinuplasty had fewer postoperative problems than FESS and powered instrumentation, including bleeding, infection, and synechia.
Balloon sinuplasty treats CRS better than FESS and powered instrumentation and has fewer postoperative sequelae. These data imply that balloon sinuplasty may be a preferred FESS surgical strategy for CRS, but patient-specific characteristics and disease severity must be considered. Current findings need to be confirmed by larger studies with longer follow-up periods to determine the best FESS surgical strategy for CRS.
当前研究比较了传统功能性鼻内镜鼻窦手术(FESS)、球囊鼻窦成形术和电动器械在慢性鼻-鼻窦炎(CRS)治疗中的效果。
对150例接受FESS的CRS患者进行前瞻性对比分析。手术方法将患者分为三组:A组(传统FESS,n = 50)、B组(球囊鼻窦成形术,n = 50)和C组(电动器械,n = 50)。主要观察指标包括症状缓解情况,术前及术后6个月使用“22项鼻-鼻窦结局测试(SNOT-22)”进行测量。术前及术后6个月的“简明健康调查问卷(SF-36)”评估术后并发症及生活质量。
球囊鼻窦成形术在缓解症状方面优于FESS和电动器械。球囊鼻窦成形术组SNOT-22平均得分降低了62.1%,远高于标准FESS组和电动器械组(分别为49.1%和45.8%)(P < 0.001)。球囊鼻窦成形术术后问题少于FESS和电动器械,包括出血、感染和粘连。
球囊鼻窦成形术治疗CRS比FESS和电动器械效果更好,且术后后遗症更少。这些数据表明球囊鼻窦成形术可能是CRS首选的FESS手术策略,但必须考虑患者的具体特征和疾病严重程度。目前的研究结果需要通过更大规模、更长随访期的研究来证实,以确定CRS最佳的FESS手术策略。